CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome [Phase 4]
Summary
A Phase 4 clinical trial updating the effectivity of postpartum dexamethasone for women with Class I HELLP syndrome has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Materno Infantil Prof. Fernando Figueira | Conditions: HELLP Syndrome | Phase 4 | Status: TERMINATED